rs77169590
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000324288.14(CIITA):c.370C>A(p.Pro124Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000706 in 1,613,836 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P124P) has been classified as Likely benign.
Frequency
Consequence
ENST00000324288.14 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIITA | NM_000246.4 | c.370C>A | p.Pro124Thr | missense_variant | 5/20 | ENST00000324288.14 | NP_000237.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIITA | ENST00000324288.14 | c.370C>A | p.Pro124Thr | missense_variant | 5/20 | 1 | NM_000246.4 | ENSP00000316328 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00371 AC: 564AN: 151842Hom.: 5 Cov.: 31
GnomAD3 exomes AF: 0.00106 AC: 267AN: 251492Hom.: 0 AF XY: 0.000692 AC XY: 94AN XY: 135920
GnomAD4 exome AF: 0.000393 AC: 574AN: 1461876Hom.: 1 Cov.: 32 AF XY: 0.000327 AC XY: 238AN XY: 727236
GnomAD4 genome AF: 0.00372 AC: 565AN: 151960Hom.: 5 Cov.: 31 AF XY: 0.00347 AC XY: 258AN XY: 74262
ClinVar
Submissions by phenotype
CIITA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 11, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
MHC class II deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at